NCT07416838

Quality of Life and Cognitive Functioning in Patients With Glial Tumors

Quality of Life and Cognitive Functioning as Prognostic Factor in Glial Tumours

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 90 (actual)
• Sponsor: Institute of Oncology Ljubljana · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The aim of this study is to introduce appropriate assessment instruments and to define patients with gliomas according to cognitive functioning and quality of life. The study will evaluate cognitive functioning as a prognostic factor for survival in patients with glial tumors and will support optimization of treatment strategies to improve patients' quality of life.

Detailed description

This prospective cohort study will assess cognitive functioning and quality of life in patients with glial tumors. The objective is to determine the prognostic value of cognitive functioning on survival, establish appropriate assessment instruments, and contribute to treatment adaptation with the goal of improving quality of life in these patients.

Conditions

• Glial Tumors

Interventions

Type	Name	Description
OTHER	Cognitive Functioning and Quality of Life Assessment	Assessment of cognitive functioning and quality of life in patients with glial tumors to evaluate their prognostic value and impact on survival outcomes.

Timeline

• Start date: 2018-09-21
• Primary completion: 2024-12-31
• Completion: 2024-12-31
• First posted: 2026-02-18
• Last updated: 2026-02-18

Locations

1 site across 1 country: Slovenia